Analysis & Opinions
November 27, 2012
Pluristem Therapeutics, Inc. (PSTI) recently provided an update on its efforts to gain orphan drug status for its ...
November 07, 2012
Osiris Therapeutics Inc. (OSIR) reported a third quarter loss of 9 cents per share, narrower than the Zacks ...
October 01, 2012
Osiris Therapeutics, Inc. (OSIR) recently announced that it has regained global rights to Prochymal and Chondrogen ...
July 03, 2012
Osiris Therapeutics, Inc. (OSIR) recently reported encouraging data from a study that evaluated its stem cell ...
June 22, 2012
We recently reiterated our Neutral recommendation on Osiris Therapeutics, Inc. (OSIR). Osiris, a stem cell ...
June 18, 2012
Just a few weeks after gaining approval in Canada, Osiris Therapeutics, Inc.'s (OSIR) stem cell therapy, Prochymal, ...
June 15, 2010
Stem cells get a lot of attention, but maybe not in the one area where they could prove most effective.